胎儿中枢神经系统异常:何时应提供外显子组测序?
该研究回顾两个未选择队列的三人家系外显子组测序结果,分析268例产前超声发现中枢神经系统异常的胎儿。孤立单一中枢神经系统异常者7/97(7.2%)检出可能致病/致病变异,多发中枢神经系统异常者12/63(19%),合并其他器官系统异常者18/108(16.7%)。结论认为外显子组测序是产前评估任何中枢神经系统异常胎儿的重要工具。
要点
- 孤立单一中枢神经系统异常胎儿中7/97(7.2%)检出可能致病/致病变异。
- 孤立轻度脑室扩大胎儿中3/23(13%)检出可能致病/致病变异。
- 多发中枢神经系统异常及多系统异常胎儿检出率较高,分别为12/63(19%)和18/108(16.7%)。
核心结论
- 外显子组测序是产前评估任何中枢神经系统异常胎儿的重要工具。
- 可能致病/致病变异率在多发中枢神经系统异常和多系统异常胎儿中趋于最高,但外显子组测序对孤立中枢神经系统异常也可能有益。
研究设计与样本
- 回顾两个既往报道的未选择队列(Prenatal Assessment of Genomes and Exomes(PAGE)和CUIMC)的三人家系外显子组测序结果,纳入核型和染色体微阵列无明显异常的胎儿中枢神经系统异常病例。
- 共对268例产前超声发现中枢神经系统异常的妊娠进行了外显子组测序。
- 变异按ACMG指南分类,并探讨致病性变异与特定类型中枢神经系统异常的关联。
主要发现
- 孤立单一中枢神经系统异常胎儿中7/97(7.2%)检出可能致病/致病变异。
- 孤立轻度脑室扩大胎儿中3/23(13%)检出可能致病/致病变异。
- 孤立胼胝体发育不全胎儿中3/10(30%)检出可能致病/致病变异。
- 中枢神经系统多发异常胎儿中12/63(19%)检出可能致病/致病变异。
- 中枢神经系统合并其他器官系统异常胎儿中18/108(16.7%)检出可能致病/致病变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the detection of pathogenic variants using exome sequencing in an international cohort of fetuses with central nervous system (CNS) anomalies. METHODS: We reviewed trio exome sequencing (ES) results for two previously reported unselected cohorts (Prenatal Assessment of Genomes and Exomes (PAGE) and CUIMC) to identify fetuses with CNS anomalies with unremarkable karyotypes and chromosomal microarrays. Variants were classified according to ACMG guidelines and association of pathogenic variants with specific types of CNS anomalies explored. RESULTS: ES was performed in 268 pregnancies with a CNS anomaly identified using prenatal ultrasound. Of those with an isolated, single, CNS anomaly, 7/97 (7.2%) had a likely pathogenic/pathogenic (LP/P) variant. This includes 3/23 (13%) fetuses with isolated mild ventriculomegaly and 3/10 (30%) fetuses with isolated agenesis of the corpus callosum. Where there were multiple anomalies within the CNS, 12/63 (19%) had LP/P variants. Of the 108 cases with CNS and other organ system anomalies, 18 (16.7%) had LP/P findings. CONCLUSION: ES is an important tool in the prenatal evaluation of fetuses with any CNS anomaly. The rate of LP/P variants tends to be highest in fetuses with multiple CNS anomalies and multisystem anomalies, however, ES may also be of benefit for isolated CNS anomalies.
引用
- Baptiste C, Mellis R, Aggarwal V, et al. Fetal central nervous system anomalies: When should we offer exome sequencing? Prenat Diagn. 2022. PMID: 35411553. doi:10.1002/pd.6145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。